Mouse Recombinant Monoclonal AAV8 antibody. Carrier free. Suitable for I-ELISA, Dot and reacts with Recombinant fragment - Adeno-associated virus 3B, Recombinant fragment - Adeno-associated virus - 8 samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
I-ELISA | Dot | |
---|---|---|
Adeno-associated virus - 8 | Predicted | Predicted |
Adeno-associated virus 3B | Predicted | Predicted |
Recombinant fragment - Adeno-associated virus - 8 | Tested | Tested |
Recombinant fragment - Adeno-associated virus 3B | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Adeno-associated virus 3B, Recombinant fragment - Adeno-associated virus - 8 | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Adeno-associated virus - 8, Adeno-associated virus 3B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Adeno-associated virus 3B, Recombinant fragment - Adeno-associated virus - 8 | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Adeno-associated virus - 8, Adeno-associated virus 3B | Dilution info - | Notes - |
Select an associated product type
AAV3B
Adeno-associated virus - 8
Mouse Recombinant Monoclonal AAV8 antibody. Carrier free. Suitable for I-ELISA, Dot and reacts with Recombinant fragment - Adeno-associated virus 3B, Recombinant fragment - Adeno-associated virus - 8 samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
ab315830 is the carrier-free version of Anti-AAV8 + AAV3B antibody [HL2383-IgG1] ab315829.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Adeno-associated virus serotype 8 (AAV8) and AAV3B are variants belonging to the parvovirus family known for their roles as vectors in gene therapy. These serotypes do not have a known mass as they are not proteins but viral capsids made up of proteins. AAV8 and AAV3B are expressed by recombinant technology and utilized as delivery vehicles in various tissues and cells. AAV8 is especially known for its efficiency in transducing liver muscle and retina while AAV3B shows strong affinity for human hepatocytes.
AAV8 and AAV3B lack replicative properties in the absence of a helper virus making them a safe choice for gene delivery systems. Unlike proteins that are part of a complex these viruses exist independently but rely on the host cellular machinery for successful transduction. Through their distinct tissue tropisms these serotypes enable targeted delivery of genetic material which enhances therapeutic outcomes.
AAV8 and AAV3B integrate into host cell processes by hijacking the endosomal trafficking and nuclear import pathways. They remain episomal avoiding integration into the host genome reducing the risk of insertional mutagenesis. AAV3B specifically associates with serotypes like AAV2 in receptor binding and entry pathways which can impact its efficacy and targeting strategy in therapeutic applications.
AAV8 has shown significant potential in liver-targeted therapies particularly in the treatment of hemophilia by delivering functional copies of the factor IX gene. AAV3B on the other hand is under investigation for its role in targeting hepatocellular carcinoma cells due to its affinity for hepatocytes. Collaboration with proteins like the erythroblastic leukemia viral oncogene homolog 2 (ErbB2) aids AAV3B's therapeutic strategies by honing its specificity to cancerous cells.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-AAV8 + AAV3B antibody [HL2383-IgG1] ab315829, the same antibody clone in a different buffer formulation.
Dot blot analysis of AAV8 + AAV3B using Anti-AAV8 + AAV3B antibody [HL2383-IgG1] ab315829 at 1:2000 (0.5 ug/ml) followed by a Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1:5000 dilution.
Dot blot was performed using 1 ng of each capsid loaded per well.
Anti-AAV9 antibody [HL2368] (Anti-AAV9 antibody [HL2368] ab315818) (1:2000), Anti-AAV9 antibody [HL2370] (Anti-AAV9 antibody [HL2370] ab315820) (1:2000), Anti-AAV9 antibody [HL2374] (Anti-AAV9 antibody [HL2374] ab315823) (1:2000), and Anti-AAV9 antibody [HL2374-IgG1] - BSA and Azide free (Anti-AAV9 antibody [HL2374-IgG1] - BSA and Azide free ab315826) (1:2000) specifically recognize AAV9 capsid.
Anti-AAV8 + AAV3B antibody [HL2383] (Anti-AAV8 + AAV3B antibody [HL2383] ab315827) (1:2000), and Anti-AAV8 + AAV3B antibody [HL2383-IgG1] (Anti-AAV8 + AAV3B antibody [HL2383-IgG1] ab315829) (1:2000) specifically recognize AAV8/3B capsid.
Anti-AAV8 + AAV9 antibody [HL2372] (Anti-AAV8 + AAV9 antibody [HL2372] ab315821) (1:2000) specifically recognizes AAV8/9 capsid.
Anti-AAV5 antibody [HL2476] (Anti-AAV5 antibody [HL2476] ab315831) (1:2000) specifically recognizes AAV5 capsid.
Developed using the ECL technique.
Exposure time: 8min
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com